← board
HSTC
distress 5/10 · elevated risk$0.700%today-33% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
0.3 yrs
Shares 1y
+17%
Price & events
-29.3% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
+0.0%
1W
+0.0%
1M
+12.0%
3M
-29.3%
6M
+174900.0%
1Y
-33.3%
2Y
+636.8%
5Y
+872.2%
All
Overview
- Market Cap
- $29.94M
- Volume
- 0
- 52 Week Range
- $0.00 – $1.05
- Total Shares
- 42.77M
- Float Shares
- 33.19M
- % Held by Insiders
- 44.52%
- % Held by Institutions
- 0.00%
- Beta
- -367.74
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.